Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months – 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    Czechia Denmark France Germany Hungary Italy +1
  • Study on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Germany Italy The Netherlands +2
  • Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Czechia France Germany Hungary Ireland +5
  • Study Comparing Sacituzumab Govitecan with Standard Treatment for Patients with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

    Not recruiting

    1 1 1 1
    Denmark
  • Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

    Not recruiting

    1 1
    Investigated drugs:
    Austria Belgium France Germany Hungary Italy +2
  • Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

    Not recruiting

    1 1
    Investigated drugs:
    Denmark Ireland
  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    1 1
    Investigated drugs:
    Czechia Denmark France Germany Italy The Netherlands +2
  • Study on Esketamine for Long-term Pain Relief in Patients with Complex Regional Pain Syndrome

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effects of GLM101 for Patients with PMM2-CDG

    Not recruiting

    1 1
    Spain